Attention-Deficit-Hyperactivity-Disorder-Adhd Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Association of the Cannabinoid Receptor Gene (CNR1) With ADHD and Post-Traumatic Stress Disorder (2009)

    These observations suggest that the cannabinoid receptor gene (CNR1) may be a risk factor for ADHD and possibly TTPT, and that this gene deserves further investigation for a role in neuropsychiatric disorders. View study

  • Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat�an animal model of attention deficit hyperactivity disorder (2008)

    This research was based on comparing the motivational effects of the synthetic cannabinoid agonist WIN55,212-2 (WIN) in adolescent and adult rats with spontaneous hypertension (SHR), a validated animal model of attention deficit / hyperactivity disorder (ADHD) and rats Wistar, which represent a normal genetically heterogeneous population. It was possible to conclude in this study that the contrasting effects of WIN in Wistar and SHR, and the greater resistance of adolescent rats to the aversive and satisfactory effects of WIN in these two strains suggest that both adolescence and the profile similar to ADHD that presents the SHR strain are factors that influence the motivational properties of cannabinoids. View study

  • Cannabis improves symptoms of ADHD (2008)

    This research showed that some people with attention deficit / hyperactivity disorder (ADHD) that is related to lack of attention and an activated level of disturbance. They can benefit from the consumption of tetrahydrocannabinol (THC), and give them a better behavioral performance. View study

  • Drug Reinforcement in a Rat Model of Attention Deficit-Hyperactivity Disorder � The Spontaneously Hypertensive Rat (SHR) (2009)

    In this investigation, the study was carried out in a model of attention deficit hyperactivity disorder (ADHD) in rats: the spontaneously hypertensive rat (SHR) using a pharmacological reinforcement. The results reviewed show that the SHR strain is a promising tool for studies on drug addiction and, possibly, its relationship with (ADHD). View study

  • Methods of the Pharmacological Imaging of the Cannabinoid System (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition (2011)

    This article narrates the objectives and methods of the pharmacological image study of the PhICS cannabinoid system and shows the preliminary results of the administration procedure on subjective and neurophysiological parameters. The preliminary results presented in this document indicate solid behavioral and subjective effects of the acute effects of the Cannabinoid agonist 9-tetrahydrocannabinol (THC). View study